Image Courtesy: CNN
China has become the first country to approve a commercially available invasive brain-computer interface, marking a significant milestone in the global race to connect the human brain directly with digital systems.
The device, known as NEO, has received regulatory approval from China’s National Medical Products Administration and is set to enter commercial production. Developed by Shanghai-based startup Neuracle Technology in partnership with researchers at Tsinghua University, the implant reached the market before Elon Musk’s Neuralink, which remains in the clinical testing phase despite beginning human trials in 2024.
The achievement highlights how engineering choices can shape regulatory outcomes. While Neuralink’s N1 implant relies on ultra-thin electrodes inserted directly into the brain’s cortex using a specialized robotic surgeon, NEO takes a less invasive approach. Its sensors sit on the dura mater, the protective membrane surrounding the brain, allowing it to capture neural signals without penetrating brain tissue.
Experts say that design likely helped accelerate approval by reducing risks associated with bleeding, immune reactions, tissue damage, and long-term scarring. The tradeoff is that the device captures broader brainwave activity rather than the highly detailed neuron-level signals targeted by more invasive systems.
For now, NEO is focused on medical rehabilitation. In clinical trials, paralyzed patients used the implant to control a robotic glove that helped them perform everyday tasks such as grasping objects, eating, and drinking independently. The technology is intended to support patients suffering from neurological and movement disorders, a population that numbers in the billions worldwide.
The approval comes as governments and technology companies invest heavily in brain-computer interfaces, a sector projected to grow into a multi-billion-dollar industry over the next decade. Researchers believe the technology could eventually restore mobility, communication, and sensory functions for patients with severe disabilities.
Beyond healthcare, however, the technology carries broader implications. Advocates envision future systems that could enable direct interaction with computers, digital communication through thought alone, and new forms of human-machine collaboration. Those possibilities have fueled investment from both Silicon Valley and state-backed research programs around the world.
At the same time, privacy and cybersecurity experts have warned that brain-computer interfaces introduce unprecedented risks. Unlike smartphones or wearable devices, neural implants process signals generated directly by the brain, raising concerns about data security, surveillance, and the potential misuse of highly personal cognitive information.
As brain-computer technology moves from research labs into commercial deployment, regulators will face the challenge of balancing transformative medical benefits with questions surrounding privacy, security, and the protection of human cognition itself.